Functional similarities and uniqueness of p27 and p57: Insight from a knock-in mouse model

Cell Cycle

Volumn 8, Issue 16, 2009, Pages 2497-2501

  Susaki, Etsuo ^b   Nakayama, Keiichi I ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b NONE

Author keywords

Knock in mouse; Knockout mouse; p27; p53; p57

Indexed keywords

CYCLIN DEPENDENT KINASE; PROTEIN P27; PROTEIN P57;

ANIMAL CELL; APOPTOSIS; CELL CYCLE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL FUNCTION; CELL TYPE; ENZYME INHIBITION; GENE EXPRESSION REGULATION; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN STRUCTURE; REVIEW; TUMOR CELL;

MUS;

EID: 69249232305     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.8.16.9330     Document Type: Review

References (57)

1. Kip2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution. Genes Dev 1995; 9:639-649
2. Cip1 CDK inhibitor family, is a candidate tumor suppressor gene. Genes Dev 1995; 9:650-662
3. 1 cyclin-CDK protein kinase activity, is related to p21. Cell 1994; 78:67-74.
4. Polyak K, Lee MH, Erdjument-Bromage H, Koff A, Roberts JM, Tempst P, et al. Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals. Cell 1994; 78:59-66. (Pubitemid 2117026)
5. Yokoo T, Toyoshima H, Miura M, Wang Y, Iida KT, Suzuki H, et al. p57Kip2 regulates actin dynamics by binding and translocating LIM-kinase 1 to the nucleus. J Biol Chem 2003; 278:52919-52923 (Pubitemid 38035893)
6. Kip2 during mouse development. Anat Embryol 2001; 203:77-87.
7. Kip1. Cell 1996; 85:721-732
8. Kip1-deficient mice. Cell 1996; 85:733-744
9. Kip1 display increased body size, multiple organ hyperplasia, retinal dysplasia and pituitary tumors. Cell 1996; 85:707-720
10. Kip2 indicates a role in Beckwith-Wiedemann syndrome. Nature 1997; 387:151-158
11. Kip2, exhibit skeletal abnormalities and growth retardation. J Biochem 2000; 127:73-83.
12. Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev 1997; 11:973-983
13. Susaki E, Nakayama K, Yamasaki L, Nakayama KI. Common and specific roles of the related CDK inhibitors p27 and p57 revealed by a knock-in mouse model. Proc Natl Acad Sci USA 2009; 106:5192-5197
14. 1 phase. Nat Cell Biol 2004; 6:1229-1235
15. 1 phase of the cell cycle. Mol Cell Biol 2005; 25:9292-9303
16. Kotoshiba S, Kamura T, Hara T, Ishida N, Nakayama KI. Molecular dissection of the interaction between p27 and Kip1 ubiquitylation-promoting complex, the ubiquitin ligase that regulates proteolysis of p27 in G1 phase. J Biol Chem 2005; 280:17694-17700 (Pubitemid 41389006)
17. Kip2 in liver development. FEBS Lett 2000; 483:160-164
18. Kip1 distinguish pituitary progenitor cell cycle exit from cell cycle reentry of differentiated cells. Mol Cell Biol 2009; 29:1895-1908
19. Kip2 in the intracellular timer that controls oligodendrocyte differentiation. J Neurosci 2007; 27:6185-6196
20. Kip2 regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina. Development 2000; 127:3593-3605
21. Georgia S, Soliz R, Li M, Zhang P, Bhushan A. p57 and Hes1 coordinate cell cycle exit with self-renewal of pancreatic progenitors. Dev Biol 2006; 298:22-31. (Pubitemid 44414792)
22. Gui H, Li S, Matise MP. A cell-autonomous requirement for Cip/Kip cyclin-kinase inhibitors in regulating neuronal cell cycle exit but not differentiation in the developing spinal cord. Dev Biol 2007; 301:14-26. (Pubitemid 44958402)
23. Kip2 during embryo morphogenesis. Mech Dev 2001; 109:83-89
24. Cobrinik D, Lee MH, Hannon G, Mulligan G, Bronson RT, Dyson N, et al. Shared role of the pRB-related p130 and p107 proteins in limb development. Genes Dev 1996; 10:1633-1644 (Pubitemid 26268868)
25. Morgenbesser SD, Williams BO, Jacks T, DePinho RA. p53-dependent apoptosis produced by Rb-deficiency in the developing mouse lens. Nature 1994; 371:72-74 (Pubitemid 24277466)
26. Macleod KF, Hu Y, Jacks T. Loss of Rb activates both p53-dependent and independent cell death pathways in the developing mouse nervous system. EMBO J 1996; 15:6178-6188 (Pubitemid 26397890)
27. Liu Y, Zacksenhaus E. E2F1 mediates ectopic proliferation and stage-specific p53- dependent apoptosis but not aberrant differentiation in the ocular lens of Rb deficient fetuses. Oncogene 2000; 19:6065-6073 (Pubitemid 32039381)
28. Tsai KY, Hu Y, Macleod KF, Crowley D, Yamasaki L, Jacks T. Mutation of E2F1 suppresses apoptosis and inappropriate S phase entry and extends survival of Rb-deficient mouse embryos. Mol Cell 1998; 2:293-304. (Pubitemid 128379270)
29. Saavedra HI, Wu L, de Bruin A, Timmers C, Rosol TJ, Weinstein M, et al. Specificity of E2F1, E2F2 and E2F3 in mediating phenotypes induced by loss of Rb. Cell Growth Differ 2002; 13:215-225
30. Kamijo T, Weber JD, Zambetti G, Zindy F, Roussel MF, Sherr CJ. Functional and physical interactions of the ARF tumor suppressor with p53 and MDM2. Proc Natl Acad Sci USA 1998; 95:8292-8297 (Pubitemid 28326106)
31. ARF, interacts with MDM2 and neutralizes MDM2's inhibition of p53. Cell 1998; 92:713-723
32. ARF, participates in a regulatory feedback loop with p53 and MDM2. EMBO J 1998; 17:5001-5014
33. Zhang Y, Xiong Y, Yarbrough WG. ARF promotes MDM2 degradation and stabilizes p53: ARF-Ink4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell 1998; 92:725-734 (Pubitemid 28155312)
34. ARF links the tumour suppressors Rb and p53. Nature 1998; 395:124-125
35. ARF tumor suppressor. Mol Cell Biol 2000; 20:273-285
36. Rogoff HA, Pickering MT, Debatis ME, Jones S, Kowalik TF. E2F1 induces phosphorylation of p53 that is coincident with p53 accumulation and apoptosis. Mol Cell Biol 2002; 22:5308-5318
37. Russell JL, Powers JT, Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. ARF differentially modulates apoptosis induced by E2F1 and Myc. Mol Cell Biol 2002; 22:1360-1368
38. Hsieh JK, Yap D, O'Connor DJ, Fogal V, Fallis L, Chan F, et al. Novel function of the cyclin A binding site of E2F in regulating p53-induced apoptosis in response to DNA damage. Mol Cell Biol 2002; 22:78-93.
39. Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis. Mol Cancer Res 2004; 2:203-214
40. Moberg KH, Bell DW, Wahrer DC, Haber DA, Hariharan IK. Archipelago regulates cyclin E levels in Drosophila and is mutated in human cancer cell lines. Nature 2001; 413:311-316
41. Strohmaier H, Spruck CH, Kaiser P, Won KA, Sangfelt O, Reed SI. Human F-box protein hCDC4 targets cyclin E for proteolysis and is mutated in a breast cancer cell line. Nature 2001; 413:316-322
42. Fbw7 ubiquitin ligase. Science 2001; 294:173-177
43. Yada M, Hatakeyama S, Kamura T, Nishiyama M, Tsunematsu R, Imaki H, et al. Phosphorylation-dependent degradation of c-Myc is mediated by the F-box protein Fbw7. EMBO J 2004; 23:2116-2125
44. Welcker M, Orian A, Jin J, Grim JE, Harper JW, Eisenman RN, et al. The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation- dependent c-Myc protein degradation. Proc Natl Acad Sci USA 2004; 101:9085-9090
45. Hubbard EJ, Wu G, Kitajewski J, Greenwald I. Sel-10, a negative regulator of Lin-12 activity in Caenorhabditis elegans, encodes a member of the CDC4 family of proteins. Genes Dev 1997; 11:3182-3193
46. Gupta-Rossi N, Le Bail O, Gonen H, Brou C, Logeat F, Six E, et al. Functional interaction between Sel-10, an F-box protein, and the nuclear form of activated Notch1 receptor. J Biol Chem 2001; 276:34371-34378
47. Oberg C, Li J, Pauley A, Wolf E, Gurney M, Lendahl U. The Notch intracellular domain is ubiquitinated and negatively regulated by the mammalian Sel-10 homolog. J Biol Chem 2001; 276:35847-35853
48. Wu G, Lyapina S, Das I, Li J, Gurney M, Pauley A, et al. Sel-10 is an inhibitor of Notch signaling that targets Notch for ubiquitin-mediated protein degradation. Mol Cell Biol 2001; 21:7403-7415
49. Fbw7 antagonizes apoptotic JNK signaling. Science 2004; 303:1374-1378
50. Onoyama I, Tsunematsu R, Matsumoto A, Kimura T, De Alboran IM, Nakayama K, et al. Conditional inactivation of Fbxw7 impairs cell cycle exit during T cell differentiation and results in lymphomatogenesis. J Exp Med 2007; 204:2875-2888
51. Onoyama I, Nakayama KI. Fbxw7 in cell cycle exit and stem cell maintenance: insight from gene-targeted mice. Cell Cycle 2008; 7:3307-3313
52. Vousden KH, Prives C. Blinded by the light: the growing complexity of p53. Cell 2009; 137:413-431
53. Kruse JP, Gu W. Modes of p53 regulation. Cell 2009; 137:609-622
54. Nishiyama M, Oshikawa K, Tsukada Y, Nakagawa T, Iemura S, Natsume T, et al. CHD8 suppresses p53-mediated apoptosis through histone H1 recruitment during early embryogenesis. Nat Cell Biol 2009; 11:172-182
55. Bensaad K, Vousden KH. p53: new roles in metabolism. Trends Cell Biol 2007; 17:286-291
56. Spencer SL, Gaudet S, Albeck JG, Burke JM, Sorger PK. Non-genetic origins of cell-to-cell variability in TRAIL-induced apoptosis. Nature 2009; 459:428-432
57. Janes KA, Reinhardt HC, Yaffe MB. Cytokine-induced signaling networks prioritize dynamic range over signal strength. Cell 2008; 135:343-354